REG - Indivior PLC - Director Declaration

IndiviorAnnouncement

18/05/2022 10:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220518:nRSR9434La&default-theme=true

RNS Number : 9434L  Indivior PLC  18 May 2022

Indivior PLC (the 'Company')

Director Declaration

 

In accordance with Listing Rule 9.6.14(R), the Company confirms that Jo
LeCouilliard, Non-Executive Director, will be appointed Chair of Alliance
Pharma plc (AIM: APH) effective May 2023.  Ms Le Couilliard has served as a
Non-Executive Director of Alliance Pharma PLC (AIM: APH) since January 2019.

 

There have been no other changes to the information set out in LR 9.6.13R (2)
to LR 9.6.13R (6) in respect of Ms LeCouilliard.

 

Contact:             Kathryn Hudson

Company Secretary
Tel: +44 (0)1753 423940 / cosec@indivior.com

Jason Thompson
Vice President, Investor Relations

Tel: +1-804-402-7123 / jason.thompson@indivior.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RDNBKFBKCBKKAPD